Advertisement
Screener

GeneDx Holdings Corp. (WGS) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

GeneDx Holdings Corp. Cash Flow Breakdown

Cash flow breakdown shows where GeneDx Holdings Corp.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $33.28M came in.
  • Fiscal year ended 2025-12-31: from investing, $61.52M went out.
  • Fiscal year ended 2025-12-31: from financing, $48.02M came in.
  • Fiscal year ended 2025-12-31: change in cash, $19.79M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew debtNew shares soldNot split outChange in cash
2025-12-31$33.28M-$61.52M$0.00$2.02M$46.00M*$19.79M
2024-12-31-$28.50M-$30.13M$0.00$394.00K$43.77M*-$14.47M
2023-12-31-$180.15M-$43.73M$48.55M$285.00K$137.40M*-$37.63M
2022-12-31-$319.15M-$141.33M$0.00$197.66M-$263.17M
2021-12-31-$190.43M-$20.79M$0.00$350.00M$143.73M*$282.51M
2020-12-31-$93.13M-$31.97M$15.93M$0.00$113.13M*$3.95M
2019-12-31-$18.73M-$15.46M$0.00$0.00$148.01M*$113.83M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$28.98M*-$5.63M*$0.00*$1.00M*
2026-03-31-$32.41M-$17.25M$476.00K$38.11M*-$11.07M
2025-12-31-$3.09M*-$11.07M*$1.04M*$22.15M*
2025-09-30$15.77M*-$4.69M*$182.00K*$10.59M*
2025-06-30$10.42M*-$36.35M*$0.00*
2025-03-31$10.18M-$9.41M$0.00$13.72M*$14.49M
2024-12-31-$3.18M*-$519.00K*$147.00K*$30.88M*
2024-09-30-$4.39M*-$7.75M*$86.00K*$13.88M*
2024-06-30-$4.50M*-$22.70M*$137.00K*
2024-03-31-$16.41M$843.00K$24.00K-$16.01M
2023-12-31-$29.86M*-$4.86M*$19.00K*$47.08M*
2023-09-30-$41.23M*-$27.13M*$0.00*-$911.00K*
2023-06-30-$53.50M*-$11.27M*$0.00*$0.00*$7.39M*
2023-03-31-$55.56M-$462.00K$266.00K$132.39M*$76.64M
2022-12-31-$64.65M*-$2.84M*$725.00K*
2022-09-30-$88.36M*-$4.28M*$404.00K*-$1.05M*
2022-06-30-$84.64M*-$130.30M*$0.00*$1.12M*$196.94M*
2022-03-31-$81.49M-$3.91M$0.00$702.00K*-$85.57M
2021-12-31-$51.98M*-$7.69M*$0.00*$0.00*-$1.03M*
2021-09-30-$70.94M*-$3.62M*$350.00M*$149.41M*
2021-06-30-$25.30M*-$4.48M*-$454.00K*$552.00K*-$2.47M*
2021-03-31-$42.21M-$4.99M-$394.00K$422.00K-$2.31M*-$49.48M
2020-12-31-$20.30K*$0.00*$9.93M*$0.00*
2020-09-30-$365.81K-$442.75M$444.26M*$1.14M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
Pennant Group, Inc. (PNTG)United States$1.386B39.84
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Omada Health, Inc. (OMDA)United States$1.207B309.08
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B